0001054074-23-000003.txt : 20230620 0001054074-23-000003.hdr.sgml : 20230620 20230620120509 ACCESSION NUMBER: 0001054074-23-000003 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc. CENTRAL INDEX KEY: 0001720893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821386754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38410 FILM NUMBER: 231024140 BUSINESS ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-643-8060 MAIL ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 144 144 1 primary_doc.xml 144 0001256126 XXXXXXXX LIVE 0001720893 BioXcel Therapeutics, Inc. 001-38410 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060 MUELLER PETER Officer common Cowen & Company, LLC

Lexington Ave New York NY 10022

96993 1939860.00 29159638 06/20/2023 NASDAQ Common 06/21/2018 restricted stock units BioXcel Therapeutics N 96993 06/21/2018 Company Compensation Y 06/20/2023 03/21/2023 /s/ Peter Mueller